The Orphan Drugs Market outlook remains exceptionally positive as the industry transitions from chronic management to curative interventions. With the global rare disease patient population exceeding 400 million, the demand for effective therapies will continue to escalate. Orphan drugs' unique value proposition in addressing previously untreatable conditions positions them as an essential...